β-glucan
β-glucan is a dietary supplement with 3 clinical trials. Currently 1 active trials ongoing.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- β-glucanRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
1
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Impact of ß-glucan Supplementation on Subjective Appetite and Gastrointestinal Appetite Hormones.
Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients
Clinical Trials (3)
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Impact of ß-glucan Supplementation on Subjective Appetite and Gastrointestinal Appetite Hormones.
Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients
All 3 trials loaded
Drug Details
- Intervention Type
- Dietary supplement
- Total Trials
- 3